CoChat

20-Hydroxycholecalciferol, Product of Vitamin D3 Hydroxylation by P450scc, Decreases NF-κB Activity by Increasing IκBα Levels in Human Keratinocytes

Open access

The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.

Abstract

The side chain of vitamin D3 is hydroxylated in a sequential manner by cytochrome P450scc (CYP11A1) to form 20-hydroxycholecalciferol, which can induce growth arrest and differentiation of both primary and immortalized epidermal keratinocytes. Since nuclear factor-kappaB (NF-kappaB) plays a pivotal role in the regulation of cell proliferation, differentiation and apoptosis, we examined the capability of 20-hydroxycholecalciferol to modulate the activity of NF-kappaB, using 1,25-dihydroxycholecalciferol (calcitriol) as a positive control. 20-hydroxycholecalciferol inhibits the activation of NFkappaB DNA binding activity as well as NF-kappaB-driven reporter gene activity in keratinocytes. Also, 20-hydroxycholecalciferol induced significant increases in the mRNA and protein levels of the NF-kappaB inhibitor protein, IkappaB alpha, in a time dependent manner, while no changes in total NF-kappaB-p65 mRNA or protein levels were observed. Another measure of NF-kappaB activity, p65 translocation from the cytoplasm into the nucleus was also inhibited in extracts of 20-hydroxycholecalciferol treated keratinocytes. Increased IkappaB alpha was concomitantly observed in cytosolic extracts of 20-hydroxycholecalciferol treated keratinocytes, as determined by immunoblotting and immunofluorescent staining. In keratinocytes lacking vitamin D receptor (VDR), 20-hydroxycholecalciferol did not affect IkappaB alpha mRNA levels, indicating that it requires VDR for its action on NF-kappaB activity. Comparison of the effects of calcitrol, hormonally active form of vitamin D3, with 20-hydrocholecalciferol show that both agents have a similar potency in inhibiting NF-kappaB. Since NF-kappaB is a major transcription factor for the induction of inflammatory mediators, our findings indicate that 20-hydroxycholecalciferol may be an effective therapeutic agent for inflammatory and hyperproliferative skin diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0005988

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 P450scc (CYP11A1) can hydroxylate vitamin D3 to 20-hydroxycholecalciferol with following sequential metabolism to other hydroxyderivatives [10].
Figure 1 P450scc (CYP11A1) can hydroxylate vitamin D3 to 20-hydroxycholecalciferol with following sequential metabolism to other hydroxyderivatives [10].CC BY · PubMed Central
Figure 2 20(OH)D3 treatment inhibits the activation of NFκB DNA binding activity in keratinocytes. Nuclear extracts were prepared from human keratinocytes, normal and HaCaT, treated with 100 nM 20(OH)D3 for indicated time periods, and were subjected to EMSA (A,C). Nuclear extracts were preincubated with NF-κB antibodies (p65 and p50) and subjected to supershift assay (B,D). “Cold” represents nuclear extract preincubated with an excess of unlabelled oligonucleotide.
Figure 2 20(OH)D3 treatment inhibits the activation of NFκB DNA binding activity in keratinocytes. Nuclear extracts were prepared from human keratinocytes, normal and HaCaT, treated with 100 nM 20(OH)D3 for indicated time periods, and were subjected to EMSA (A,C). Nuclear extracts were preincubated with NF-κB antibodies (p65 and p50) and subjected to supershift assay (B,D). “Cold” represents nuclear extract preincubated with an excess of unlabelled oligonucleotide.CC BY · PubMed Central
Figure 3 20(OH)D3 treatment inhibits the activation of NFκB-dependant activity in keratinocytes. Keratinocytes were transiently transfected with a NFκB-Luc construct for 24 h then treated with 100 nM 20(OH)D3, 1,25(OH)2D3 or ethanol as a vehicle for the indicated time periods (A), or additionally stimulated with LPS (1 µg/ml) or IL-1α (10 ng/ml) for 30 min (B and C, respectively). Cell lysates prepared from HaCaT and normal human keratinocytes were assayed for luciferase activity. The data from six experiments performed in quadruplicate are presented as means±STDEV. *p<0.05 and **p<0.01 between control (non treated cells) and treated cells.
Figure 3 20(OH)D3 treatment inhibits the activation of NFκB-dependant activity in keratinocytes. Keratinocytes were transiently transfected with a NFκB-Luc construct for 24 h then treated with 100 nM 20(OH)D3, 1,25(OH)2D3 or ethanol as a vehicle for the indicated time periods (A), or additionally stimulated with LPS (1 µg/ml) or IL-1α (10 ng/ml) for 30 min (B and C, respectively). Cell lysates prepared from HaCaT and normal human keratinocytes were assayed for luciferase activity. The data from six experiments performed in quadruplicate are presented as means±STDEV. *p<0.05 and **p<0.01 between control (non treated cells) and treated cells.CC BY · PubMed Central
Figure 4 20(OH)D3 inhibits the translocation of NFκB-p65 complex into the nucleus and increases the expression of IκBα in the cytosol of keratinocytes. Primary human keratinocytes, third passage, were incubated for 4 h in KBM medium containing KGF with 100 nM 20(OH)D3 or ethanol vehicle, stimulated with IL-1α for 30 min and then fixed. Cells were stained with anti IκBα or NFκB-p65 antibody, followed by secondary antibody linked to FITC. Nuclei were stained red with propidium iodide. Cells were analyzed using fluorescent microscope at 40× magnification.
Figure 4 20(OH)D3 inhibits the translocation of NFκB-p65 complex into the nucleus and increases the expression of IκBα in the cytosol of keratinocytes. Primary human keratinocytes, third passage, were incubated for 4 h in KBM medium containing KGF with 100 nM 20(OH)D3 or ethanol vehicle, stimulated with IL-1α for 30 min and then fixed. Cells were stained with anti IκBα or NFκB-p65 antibody, followed by secondary antibody linked to FITC. Nuclei were stained red with propidium iodide. Cells were analyzed using fluorescent microscope at 40× magnification.CC BY · PubMed Central
Figure 5 20(OH)D3 increases IκBα protein concentration in keratinocytes and has no effect on NFκB-p65. Keratinocytes, HEKn and HaCaT were stimulated for the indicated times with 100 nM 20(OH)D3, and 100 nM 1,25(OH)2D3 (HEKn keratinocytes). Cells were lysed, whole cell extracts prepared, and equivalent amounts of protein were loaded onto polyacrylamide gels. Membranes were incubated with either anti-IκBα, anti-NFκB-p65 or anti β-actin (internal control) (A, C). Protein concentration expressed relative to β-actin was significantly different to the zero-time control for IκBα (p<0.05)(B, D). Results from three separate experiments are expressed as mean±STDEV.
Figure 5 20(OH)D3 increases IκBα protein concentration in keratinocytes and has no effect on NFκB-p65. Keratinocytes, HEKn and HaCaT were stimulated for the indicated times with 100 nM 20(OH)D3, and 100 nM 1,25(OH)2D3 (HEKn keratinocytes). Cells were lysed, whole cell extracts prepared, and equivalent amounts of protein were loaded onto polyacrylamide gels. Membranes were incubated with either anti-IκBα, anti-NFκB-p65 or anti β-actin (internal control) (A, C). Protein concentration expressed relative to β-actin was significantly different to the zero-time control for IκBα (p<0.05)(B, D). Results from three separate experiments are expressed as mean±STDEV.CC BY · PubMed Central
Figure 6 20(OH)D3 increases IκBα protein concentration in cytosolic extracts in keratinocytes. Normal keratinocytes were treated with 100 nM 20(OH)D3 for 1 h and 4 h and then stimulated with or without IL-1α (10 ng/ml) for 30 min. Cells were lysed in lysis buffer and cytosolic extracts prepared. An equal amount of proteins was loaded onto the polyacrylamide gel. Membranes were incubated with antibodies: anti-IκBα and anti β-actin (internal control) (A). Protein concentration expressed relative to the concentration of β-actin is shown in (B). Results are expressed as mean±STDEV.
Figure 6 20(OH)D3 increases IκBα protein concentration in cytosolic extracts in keratinocytes. Normal keratinocytes were treated with 100 nM 20(OH)D3 for 1 h and 4 h and then stimulated with or without IL-1α (10 ng/ml) for 30 min. Cells were lysed in lysis buffer and cytosolic extracts prepared. An equal amount of proteins was loaded onto the polyacrylamide gel. Membranes were incubated with antibodies: anti-IκBα and anti β-actin (internal control) (A). Protein concentration expressed relative to the concentration of β-actin is shown in (B). Results are expressed as mean±STDEV.CC BY · PubMed Central
Figure 7 20(OH)D3 increases mRNA levels of IκBα in keratinocytes. HEKn and HaCaT keratinocytes were treated with 100 nM 20(OH)D3 or 1,25(OH)2D3 or vehicle for the indicated period of time. Cells were then lysed and total RNA extracted. mRNA levels for IκBα were measured using reagents for RTPCR according to the manufacturer's protocol (Roche Applied Science, Manheim, Germany) and normalized relative to Cyclophylin B RNA. Data are presented as mean±STD (n = 3) *p<0.05 versus control, or **p<0.01 versus control. Time response in the expression of mRNA was shown for NFκBI (IκBα) in both cells.
Figure 7 20(OH)D3 increases mRNA levels of IκBα in keratinocytes. HEKn and HaCaT keratinocytes were treated with 100 nM 20(OH)D3 or 1,25(OH)2D3 or vehicle for the indicated period of time. Cells were then lysed and total RNA extracted. mRNA levels for IκBα were measured using reagents for RTPCR according to the manufacturer's protocol (Roche Applied Science, Manheim, Germany) and normalized relative to Cyclophylin B RNA. Data are presented as mean±STD (n = 3) *p<0.05 versus control, or **p<0.01 versus control. Time response in the expression of mRNA was shown for NFκBI (IκBα) in both cells.CC BY · PubMed Central
Figure 8 Silencing of the VDR in human keratinocytes attenuates the effects of 20(OH)D3 on IκBα or NFκB p65 (RelA) expression and intracellular transolaction. Keratinocytes were transfected with 2 nM scrambled or VDR siRNA and incubated with 100 nM 20(OH)D3 or vehicle (ethanol) for 4 h. Cells were lysed after treatment and total RNA extracted. VDR mRNA (A), IκBα mRNA (B) and NFκB p65 (RelA) (C) levels were measured using reagents for RTPCR according to manufacturer's protocol (Roche Applied Science, Manheim, Germany) and normalized relative to Cyclophylin B RNA. Data are presented as mean±STD (n = 3) *p<0.05 versus control, or **p<0.01 versus control. Levels of VDR and β-actin were assessed 24 h after transfection with VDR or scrambled siRNA, by western blotting of whole-cell extracts (A). 24 h after transfection with 2 nM scrambled or VDR siRNA, primary human keratinocytes were also incubated for 4 h in KBM medium containing KGF with 100 nM 20(OH)D3 or ethanol (vehicle), then fixed. Cells were stained with anti-IκBα antibody (green), followed by secondary antibody linked to FITC. Nuclei were stained red with propidium iodide (D). Another set of cells was stained with anti-p65 (green) (E). Cells were analyzed using a fluorescent microscope at 20× magnification.
Figure 8 Silencing of the VDR in human keratinocytes attenuates the effects of 20(OH)D3 on IκBα or NFκB p65 (RelA) expression and intracellular transolaction. Keratinocytes were transfected with 2 nM scrambled or VDR siRNA and incubated with 100 nM 20(OH)D3 or vehicle (ethanol) for 4 h. Cells were lysed after treatment and total RNA extracted. VDR mRNA (A), IκBα mRNA (B) and NFκB p65 (RelA) (C) levels were measured using reagents for RTPCR according to manufacturer's protocol (Roche Applied Science, Manheim, Germany) and normalized relative to Cyclophylin B RNA. Data are presented as mean±STD (n = 3) *p<0.05 versus control, or **p<0.01 versus control. Levels of VDR and β-actin were assessed 24 h after transfection with VDR or scrambled siRNA, by western blotting of whole-cell extracts (A). 24 h after transfection with 2 nM scrambled or VDR siRNA, primary human keratinocytes were also incubated for 4 h in KBM medium containing KGF with 100 nM 20(OH)D3 or ethanol (vehicle), then fixed. Cells were stained with anti-IκBα antibody (green), followed by secondary antibody linked to FITC. Nuclei were stained red with propidium iodide (D). Another set of cells was stained with anti-p65 (green) (E). Cells were analyzed using a fluorescent microscope at 20× magnification.CC BY · PubMed Central
Figure 9 A schematic representation of the effects of 20(OH)D3 on NFκB signal transduction in keratinocytes.
Figure 9 A schematic representation of the effects of 20(OH)D3 on NFκB signal transduction in keratinocytes.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

4 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Cited by

See all 133

Metadata

Authors
Janjetovic, Z., Zmijewski, M. A., Tuckey, R. C., DeLeon, D. A., Nguyen, M. N., Pfeffer, L. M., & Slominski, A. T.
Affiliations
  • University of Tennessee Health Science Center (US)
  • The University of Western Australia (AU)
Corresponding author
Slominski, Andrzej T.
Venue
PLoS ONE
Published
2009-06-19
Volume
4
Issue
6
Pages
e5988
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2018517476
Cited by
130
References
75
Citations by year
2025: 5 · 2024: 5 · 2023: 4 · 2022: 7 · 2021: 10 · 2020: 14 · 2019: 2 · 2018: 3 · 2017: 7 · 2016: 8 · 2015: 12 · 2014: 10 · 2013: 11 · 2012: 16
FWCI
3.58
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institutes of Health
  • Health Science Center, University of Tennessee
  • National Cancer Institute (R01CA133322)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR052190)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Keywords
vitamin D3 hydroxylation, CYP11A1, NF-κB, IκBα, keratinocytes, vitamin D receptor, 1,25-dihydroxyvitamin D3, p65 nuclear translocation, epidermal differentiation, skin inflammation, hyperproliferative skin diseases
MeSH terms
NF-KappaB Inhibitor alpha, Cholecalciferol, Cholesterol Side-Chain Cleavage Enzyme, Humans, Hydroxycholecalciferols, Mixed Function Oxygenases, Inflammation, Models, Biological, Transcription Factors, Immunoblotting, Keratinocytes, NF-kappa B, I-kappa B Proteins, Cell Proliferation, Interleukin-1alpha

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.